Distinct histopathological features are associated with molecular subtypes and outcome in low grade serous ovarian carcinoma

• Published in: Scientific reports 2023-05, Vol.13 (1), p.7681-10, Article 7681
• Main Authors: Hollis, Robert L., Thomson, John P., van Baal, Juliette, Ilenkovan, Narthana, Churchman, Michael, van de Vijver, Koen, Dijk, Frederike, Meynert, Alison M., Bartos, Clare, Rye, Tzyvia, Croy, Ian, Diana, Patricia, van Gent, Mignon, Creedon, Helen, Nirsimloo, Rachel, Lok, Christianne, Gourley, Charlie, Herrington, C. Simon
• Format: Article
• Language: English
• Subjects: 631/67; 631/67/1517/1709; 631/67/1857; 631/67/69; Endocrine therapy; Estrogen receptors; Female; Hormones; Humanities and Social Sciences; Humans; MAP kinase; MEK inhibitors; multidisciplinary; Ovarian cancer; Ovarian carcinoma; Ovarian Neoplasms - pathology; Peritoneal Neoplasms; Point mutation; Progesterone; Receptors, Estrogen - metabolism; Science; Science (multidisciplinary)
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-023-34627-5

Low grade serous ovarian carcinoma (LGSOC) demonstrates unique clinical and molecular features compared to other ovarian cancer types. The relationship between common histological features of LGSOC and molecular events, such as hormone receptor expression patterns and MAPK gene mutation status, remains poorly understood. Recent data suggest some of these molecular features may be biomarkers of response to recently introduced biologically-targeted therapies, namely endocrine therapy and MEK inhibitors. We utilize a cohort of 63 pathologically-confirmed LGSOC cases with whole exome sequencing and hormone receptor expression data to investigate these relationships. LGSOC cases demonstrated uniformly high oestrogen receptor (ER) expression, but variable progesterone receptor (PR) expression intensity. 60% and 37% of cases demonstrated micropapillary and macropapillary patterns of stromal invasion, respectively. 63% of cases demonstrated desmoplasia, which was significantly associated with advanced disease stage and visible residual disease after cytoreductive surgery. MAPK-mutant cases ( KRAS , BRAF , NRAS ) more frequently demonstrated macropapillary stromal invasion, while Chr1p loss was associated with desmoplasia and low PR expression. Presence of micropapillary stromal invasion and low PR expression were associated with significantly poorer survival after accounting for stage and residual disease status. Together, these data identify novel relationships between histopathological features and molecularly-defined subgroups in LGSOC.